-+ 0.00%
-+ 0.00%
-+ 0.00%

ACEPODIA ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR ACE723, A NOVEL DUAL-PAYLOAD ANTIBODY-DRUG CONJUGATE

Reuters·09/04/2026 11:00:07

Please log in to view news